Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti-CD20 × anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels
Michael Stanglmaier, Margot Faltin, Peter Ruf, Annette Bodenhausen, Petra Schröder, Horst LindhoferVolume:
123
Year:
2008
Language:
english
Pages:
9
DOI:
10.1002/ijc.23626
File:
PDF, 312 KB
english, 2008